Improved Detection of Metastases by Step Sectioning and Immuno-Histochemical Staining of Axillary Sentinel Nodes in Patients with Breast Carcinoma |
Ensani, Fereshteh
(Department of Pathology, Iran Cancer Institute, Emam Khomeini Hospital)
Enayati, Ladan (Department of Pathology, Iran Cancer Institute, Emam Khomeini Hospital) Rajabiani, Afsaneh (Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences) Omranipour, Ramesh (Department of Pathology, Iran Cancer Institute, Emam Khomeini Hospital) Alavi, Nasrinalsadat (Department of Surgery, Breast Cancer Research Center, Iranian Breast Cancer Research Center (IBCRC), Academic Center of Education Culture and Research (ACECR)) Mosahebi, Sara (Department of Surgery, Breast Cancer Research Center, Iranian Breast Cancer Research Center (IBCRC), Academic Center of Education Culture and Research (ACECR)) |
1 | Chagpar A, Middleton LP, Sahin AA et al (2005). Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer, 103, 1581-6. DOI ScienceOn |
2 | Czerniecki BJ, Scheff AM, Callans LS, et al (1999). Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer, 85, 1098-103. DOI |
3 | De Boer M, van Deurzen CH, van Dijck JA, et al (2009). Micrometastases or Isolated Tumor Cells and The Outcome of Breast Cance. N Eng J Med, 361, 653-63. DOI ScienceOn |
4 | De Boer M, Van Dijck JAAM, Bult PGF, et al (2010). Tjan-Heijnen. Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst, 102, 410-25. DOI ScienceOn |
5 | Dowlatshahi K, Fan M, Bloom K, et al (1999). Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma. A Preliminary Study Cancer, 86, 990-6. |
6 | Freneaux PP, Nos C, Salomon AV, et al (2002). Histological Detection of Minimal Metastatic Involvement in Axillary Sentinel Nodes: A Rational Basis for a Sensitive Methodology Usable in Daily Practice. Mod Pathol, 15, 641-6. DOI ScienceOn |
7 | Hansen NM, Grube B, Ye X, Turner RR, et al (2009). Impact of micrometastases in sentinel lymph node of patients with invasive breast cancer. J cli oncol, 27, 4679-84. DOI ScienceOn |
8 | Giuliano AE, Dale PS, Turner RR, et al (1995). Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg, 222, 394-401. DOI ScienceOn |
9 | Giuliano AE, Hunt KK, Ballman KV, et al (2011). Blumencranz, A. Marilyn leitch. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis a randomized clinical trial. JAMA, 305, 569-75. DOI ScienceOn |
10 | Ivens D, Hoe AL, Podd TJ (1992). Assessment of morbidity from complete axillary dissection. Br J Cancer, 66, 136-8. DOI ScienceOn |
11 | Krag DN, Anderson SJ, Julian TB, et al (2010). Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol, 11, 927-33. DOI ScienceOn |
12 | Langer G, Marti WR, Guller U, et al (2005). Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases. Ann Surg, 241, 152-8. |
13 | Lucci A, McCall LM, Beitsch PD, et al (2007). American College of Surgeons Oncology Group. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group trial Z0011. J Clin Oncol, 25, 3657-63. DOI ScienceOn |
14 | Ozcinar B, Muslumanoglu M, Igci A, et al (2011). Clinical significance of micrometastasis in sentinel lymph nodes. Breast, 20, 31-3. DOI ScienceOn |
15 | Pernas S, Gil M, Benitez A, et al (2010). Avoiding axillary treatment in sentinel lymph node micrometastasis of breast cancer: a prospective analysis of axillary or distant recurrence. Ann surg Oncol, 17, 772-7. DOI |
16 | Loya A, Guray M, Hennessy BT, et al (2009). Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer. Cancer, 115, 1605-12. DOI ScienceOn |
17 | Lyman GH, Giuliano AE, Somerfield MR, et al (2005). American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer 10. J Clin Oncol, 23, 7703-20. DOI ScienceOn |
18 | Ryde'n L, Chebil G, Sjostrom L, et al (2007). Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: Analysis of 174 patients after SLN biopsy. EJSO, 33, 33-8 DOI ScienceOn |
19 | Seung-Hye Choi SH, Barsky SH, Chang HR (2003). Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer. Breast J, 9, 153-62. DOI ScienceOn |
20 | Stitzenberg KB, Calvo BF, Iacocca MV, et al (2002). Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer. Am J Clin Pathol, 117, 729-37. |
21 | Yeoh EK, Denham JW, Davies SA (1986). Primary breast cancer: complications of axillary management. Acta Radiol Oncol, 25, 105-8. DOI |
22 | Van Zee KJ, Manasseh D-ME, Bevilacqua JLB, et al (2003). A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy. Ann Surg Oncol, 10, 1140-51. DOI ScienceOn |
23 | Veronesi U, Paganelli G, Galimberti V et al (1997). Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet, 349, 1864-7. DOI ScienceOn |
24 | Weaver DL, Krag DN, Ashikaga T, et al (2000). Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma, a multicenter study. Cancer, 88, 1099-107. DOI |
25 | Rubio IT, Korourian S, Cowan C, et al (1998). Sentinel lymph node biopsy for staging breast cancer. Am J Surg, 176, 532-7. DOI ScienceOn |
26 | Dowlatshahi K, Fan M, Snider HC, et al (1997). Lymph node micrometastases from breast carcinoma. Cancer, 80, 1188-97. DOI |
27 | Giuliano AE (1996). Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J Surg Oncol, 62, 75-6. DOI |
![]() |